Clinical Trials
4 trialsNCT02467270 2026-03-17
OPTIC
Takeda
Phase 2 Completed
NCT01844765 2021-04-22
DIALOG
Novartis
Phase 2 Completed
NCT01369498 2020-07-01
Efficacy and Safety of Simtuzumab in Adults With Primary, Post Polycythemia Vera or Post Essential Thrombocythemia Myelofibrosis
Gilead Sciences
Phase 2 Completed
NCT00113893 2013-11-07
SCIO-469: Open-Label Study for Patients With Myelodysplastic Syndromes.
Scios, Inc.
Phase 2 Completed